the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Malaysia needs time to study proposal for joint visa with six Asean countries

BANGKOK: Malaysia needs more time to consider Thailand’s proposal regarding a joint visa programme with six other Asean countries to attract more foreign tourists to the region.

Minister of Home Affairs Datuk Seri Saifuddin Nasution Ismail said the proposal is still in the early stages of discussion, and Malaysia needs to obtain more information about it.

“Thailand wants to take advantage of the collaboration of six Asean countries which have potential in tourism and economy. But Malaysia is always seeking a balance between economic potential and the interest of maintaining national security,“ he told Bernama recently.

Thailand’s Prime Minister Srettha Thavisin previously proposed a “Schengen” or joint visa initiative with Cambodia, Laos, Malaysia, Myanmar, and Vietnam to further boost tourism industry in the six-member countries, which had a combined foreign tourist arrivals of 70 million people in 2023.

ALSO READ: Make visa-free travel permanent, govt urged

In another development, Saifuddin said Malaysia is making several recommendations to China to extend the tourist visa for Malaysians to 30 days from the current 15 days.

He said the proposal will be submitted to Prime Minister Datuk Seri Anwar Ibrahim for approval first.

Since December 1, Malaysia has implemented a 30-day visa exemption for Chinese citizens, while the Chinese government has granted a 15-day visa exemption for travellers from Malaysia.

ALSO READ: China keen on mutual permanent visa-free policy with Malaysia

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings